Genetic factors, metabolism, and baseline weight significantly influence whether 1 mg, 1.7 mg, or the full 2.4 mg dose delivers your best results
With seven additional Phase 3 trials expected to read out in 2026, Retatrutide is positioning itself as potentially the most effective obesity medication ever developed
At a 2.5 mg weekly dose, that's 8 weeks of therapy
However, many mothers find that when they first start breastfeeding they experience soreness or pain in their nipples and sometimes their breasts
Novo Nordisk Targets Hims & Hers Compounded Semaglutide Offerings in Patent Lawsuit February 18, 2026 Caleb Harris On February 9, 2026, Novo Nordisk A/S and Novo Nordisk Inc
Combining a ketogenic diet (not just supplements) with GLP-1 therapy is the approach supported by clinical evidence